Does intensive follow-up alter outcome in patients with advanced lung cancer?

Journal of Thoracic Oncology

Volumn 2, Issue 4, 2007, Pages 273-281

  Benamore, Rachel ^a   Shepherd, Frances A ^a   Leighl, Natasha ^a   Pintilie, Melania ^a   Patel, Milan ^a   Feld, Ronald ^a   Herman, Stephen ^a  

^a UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

Computed tomography; Diagnostic imaging; Follow up; Non small cell lung cancer

Indexed keywords

CISPLATIN; ETOPOSIDE;

ADULT; ADVANCED CANCER; ARTICLE; BRAIN SCINTISCANNING; CANCER DIAGNOSIS; CANCER PATIENT; CANCER REGISTRY; CANCER RELAPSE; CANCER SURVIVAL; COMPARATIVE STUDY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DATA BASE; DEMOGRAPHY; DIAGNOSTIC IMAGING; FEMALE; FOLLOW UP; HOSPITAL; HUMAN; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; MALE; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RADIOLOGY; AGED; CANCER INVASION; CANCER STAGING; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; KAPLAN MEIER METHOD; LUNG TUMOR; METHODOLOGY; MIDDLE AGED; MORTALITY; PATHOLOGY; PROBABILITY; PROGNOSIS; REGISTER; RETROSPECTIVE STUDY; RISK ASSESSMENT; SECOND CANCER; TIME; TUMOR RECURRENCE;

ADULT; AGED; CARCINOMA, NON-SMALL-CELL LUNG; CLINICAL TRIALS; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIERS ESTIMATE; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEOPLASMS, SECOND PRIMARY; PROBABILITY; PROGNOSIS; REGISTRIES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 34247866503     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/01.JTO.0000263708.08332.76     Document Type: Article

References (33)

1. Jemal A, Tiwari RC, Murray T, et al. Cancer statistics, 2004. CA Cancer J Clin 2004;54:8-29.
2. Alam N, Darling G, Evans WK, et al. Adjuvant chemotherapy for completely resected non-small cell lung cancer: a systematic review. Crit Rev Oncol Hematol 2006;58:146-155.
3. Alam N, Darling G, Shepherd FA, et al. Postoperative chemotherapy in non-small cell lung cancer: a systematic review. Ann Thorac Surg 2006;81:1926-1936.
4. Booth C, Shepherd FS. Adjuvant chemotherapy for resected non-small cell lung cancer. J Thorac Oncol 2006;1:180-187.
5. Pfister G, Johnson DH, Azzoli CG, et al. American Society of Clinical Oncology treatment of unresectable non-small cell lung cancer guideline: update 2003. J Clin Oncol 2004;22:330-353.
6. Colice GL, Rubins J, Unger M. Follow-up and surveillance of the lung cancer patient following curative-intent therapy. Chest 2003;123:272S-283S.
7. Edelman MJ, Meyers FJ, Siegel D. The utility of follow-up testing after curative cancer therapy. A critical review and economic analysis. J Gen Intern Med 1997;12:318-331.
8. Rusch VW, Giroux DJ, Kraut MJ, et al. Induction chemoradiation and surgical resection for non-small cell lung carcinomas of the superior sulcus: initial results of Southwest Oncology Group Trial 9416 (Intergroup trial 0160). J Thorac Cardiovasc Surg 2001;121:472-483.
9. Albain KS, Scott CB, Rusch VR, et al. Phase III comparison of concurrent chemotherapy plus radiotherapy (CT/RT) vs CT/RT followed by surgical resection for stage IIIA(pN2) non-small cell lung cancer (NSCLC): initial results from intergroup trial 0139 (RTOG 93-09). Proc Am Soc Clin Oncol 2003;22:621, abstract 2497.
10. Virgo KS, McKirgan LW, Caputo MC, et al. Post-treatment management options for patients with lung cancer. Ann Surg 1995;222:700-710.
11. Westeel V, Choma D, Clement F, et al. Relevance of intensive postoperative follow-up after surgery for non-small cell lung cancer. Ann Thorac Surg 2000;70:1185-1190.
12. Walsh GL, O'Connor M, Willis KM, et al. Is follow-up of lung cancer patients after resection medically indicated and cost-effective? Ann Thorac Surg 1995;60:1563-1570.
13. Lamont JP, Kakuda JT, Smith D, et al. Systematic postoperative radiologic follow-up of patients with non-small cell lung cancer for detecting second primary lung cancer in stage IA. Arch Surg 2002;137:935-939.
14. Younes RN, Gross JL, Deheinzelin D. Follow-up in lung cancer: how often and for what purpose? Chest 1999;115:1494-1499.
15. Gilbert S, Reid KR, Lam MY, et al. Who should follow up lung cancer patients after operation? Ann Thorac Surg 2000;69:1696-1700.
16. Moore S, Corner J, Haviland J, et al. Nurse led follow up and conventional medical follow up in management of patients with lung cancer: randomised trial. BMJ 2002;325:1145-1151.
17. Henschke CI, McCauley DI, Yankelevitz DF, et al. Early lung cancer action project: overall design and findings from baseline screening. Lancet 1999;354:9173.
18. Chiu C-H, Chern M-S, Wu M-H, et al. Usefulness of low dose spiral CT of the chest in regular follow-up of post-operative non-small cell lung cancer patients: preliminary report. J Thorac Cardiovasc Surg 2003;125:1300-1305.
19. Yokoi K, Miyazawa N, Toshimoto A. Brain metastasis in resected lung cancer: value of intensive follow-up with computed tomography. Ann Thorac Surg 1996;61:546-551.
20. Carolan H, Sun AY, Bezjak A, et al. Does the incidence and outcome of brain metastases in locally advanced non-small cell lung cancer justify prophylactic cranial irradiation or early detection? Lung Cancer 2005;49:109-115.
21. Thomas PA, Rubinstein L. Malignant disease appearing late after operation for T1N0 non-small-cell lung cancer. The lung cancer study group. J Thorac Cardiovasc Surg 1993;106:1053-1058.
22. Johnson BE. Second lung cancers in patients after treatment for an initial lung cancer. J Natl Cancer Inst 1998;90:1335-1345.
23. Korst RJ, Gold HT, Kent MS, et al. Surveillance computed tomography after complete resection for non-small cell lung cancer: results and costs. J Thorac Cardiovasc Surg 2005;129:652-660.
24. Sause WT, Byhardt RW, Curran JrWJ et al. Follow-up of non-small cell lung cancer. American College of Radiology. ACR Appropriateness Criteria. Radiology 2000;215(Suppl):1363-1372.
25. National Institute of Clinical Excellence. The diagnosis and treatment of lung cancer. Clinical guideline 24. NICE Web site, February 2005. Available at http://www.nice.org.uk/CG024NICEguideline. Accessed August 20, 2006.
26. The NCCN Guideline. Non-small cell lung cancer Guideline, the complete library of practice guidelines in oncology (CR-ROM). Rockledge, PA: National Comprehensive Cancer Network, 2001. National Comprehensive Cancer Network. Clinical Practice Guidelines in Oncology. Non-small cell lung cancer. Version 2. 2006. Available at http://www.nccn.org/professionals/physician_gls/PDF/nscl. pdf. Accessed August 20, 2006.
27. Libshitz HI, Sheppard DG. Filling in of radiation therapy-induced bronchiectatic change: a reliable sign of locally recurrent lung cancer. Radiology 1999;210:25-27.
28. Muller LC, Salzer GM, zue Nedden D, et al. Critical checking of the radiological diagnosis of "complete remission" and "partial remission" following induction chemotherapy of small-cell lung cancer in the light of postoperative histological examination. J Thorac Cardiovasc Surg 1992;40:82-86.
29. Frank A, Lefkowitz D, Jaeger S, et al. Decision logic for retreatment of asymptomatic lung cancer recurrence based on positron emission tomography findings. Int J Radiat Oncol Biol Phys 1995;32:1495-1512.
30. Bury T, Corhay JL, Duysinx B, et al. Value of FDG-PET in detecting residual or recurrent nonsmall cell lung cancer. Eur Respir J 1999;14:1376-1380.
31. Lee J, Aronchick JM, Alavi A. Accuracy of F-18 fluorodeoxyglucose positron emission tomography for the evaluation of malignancy in patients presenting with new lung abnormalities: a retrospective review. Chest 2001;120:1791-1797.
32. Patz EF, Lowe VJ, Hoffman JM, et al. Persistent or recurrent bronchogenic carcinoma: detection with PET and 2-[F-18]-2-deoxy-D-glucose. Radiology 1994;191:379-382.
33. Hicks RJ, Kalff V, MacManus MP, et al. The utility of 18F-FDG PET for suspected recurrent non-small cell lung cancer after potentially curative therapy: impact on management and prognostic stratification. J Nucl Med 2001;42:1605-1613.